Survey on Cardiovascular Events in Patients With Metabolic Disease on Chronic Carnitine Supplementation

The purpose of this study is to learn about the effects of long term carnitine use in patients with metabolic disorders and its potential relationship to cardiovascular events.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Metabolic Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

University of South Florida

Tampa, Florida, 33612, United States

About this study

This online cross-sectional survey will examine the self-reported long-term carnitine use in patients with metabolic disorders and any potential relationship to cardiovascular events.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Diagnosis of mitochondrial disease or any other metabolic disorder
Any age group
NAMDC or RDCRN registry participant

Exclusion criteria

Inability to provide informed consent and complete survey
Lack of participation in NAMDC or RDCRN registry

Treatment and study plan

Primary outcomes

Assess how many patients with metabolic disorders are on chronic carnitine supplementation.

Time frame: Up to one year from study activation.

Secondary outcomes

Assess how many patients who are on chronic carnitine supplementation have experienced a cardiovascular event.

Time frame: Up to one year from study activation

Sponsors and collaborators

Lead sponsor

University of South Florida

Other

Collaborators

National Institutes of Health (NIH)

Registry information

Important dates

Study start: 2014
Primary completion: 2015
Study completion: 2016
First posted: Dec 8, 2014
Registry last updated: Sep 23, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed